Citadel Advisors’s Roth CH Acquisition Co. Warrant USCTW Stock Holding History

Citadel Advisors’s Portfolio USCTW Stock Details USCTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-43,329	Closed	-$611	–	15829
2024 Q1	$611	Buy	43,329 +23,707	+121%	+$562	﹤0.01%	14297
2023 Q4	$493	Buy	19,622 +998	+5%	+$48	﹤0.01%	14021
2023 Q3	$1.25K	Buy	18,624 +3,928	+27%	+$259	﹤0.01%	13889
2023 Q2	$413	Buy	+14,696	New	+$960	﹤0.01%	14124
2023 Q1	–	Sell	-18,621	Closed	-$372	–	15780
2022 Q4	$372	Buy	+18,621	New	+$544	﹤0.01%	14683

Other funds holding USCTW

CSD

Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Citadel Advisors's USCTW Position: Q2 2024 in Review

Citadel Advisors sold out of Roth CH Acquisition Co. Warrant (USCTW) in Q2 2024, closing a stake of 43,329 shares — an estimated $611 sold.

Citadel Advisors first reported a position in USCTW in Q4 2022 and held it in 5 quarters. The position peaked at $1.25K in Q3 2023. 4 funds tracked by Wall St. Rank hold USCTW as of Q2 2024.

Citadel Advisors reported no remaining Roth CH Acquisition Co. Warrant position as of Q2 2024 after selling out during the quarter.
Citadel Advisors sold 43,329 Roth CH Acquisition Co. Warrant shares in Q2 2024, an estimated $611.
Citadel Advisors first reported a position in Roth CH Acquisition Co. Warrant in Q4 2022 and held it in 5 quarters.
Citadel Advisors's Roth CH Acquisition Co. Warrant position peaked at $1.25K in Q3 2023.
4 funds tracked by Wall St. Rank held Roth CH Acquisition Co. Warrant as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.